Elanco Animal Health Reports Fourth Quarter and Full Year 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks rally, crude prices fall
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Crypto stocks rise premarket as Bitcoin hits over seven-month high
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Streamflation drives 39% of Americans to cancel streaming in 6 months
- FortuneX and WT Realty announce $600M merger deal
Elanco Animal Health (ELAN) Tops Q4 EPS by 6c; Guides FY23
February 21, 2023 6:32 AM ESTElanco Animal Health (NYSE: ELAN) reported Q4 EPS of $0.19, $0.06 better than the analyst estimate of $0.13. Revenue for the quarter came in at $988 million versus the consensus estimate of $982.82 million.
GUIDANCE:
Elanco Animal Health sees FY2023 EPS of $0.74-$0.83, versus the... More
